长链非编码rna在胰腺癌中的作用和贡献。

IF 3.6 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Transcription-Austin Pub Date : 2021-02-01 Epub Date: 2021-05-26 DOI:10.1080/21541264.2021.1922071
K T Ramya Devi, Dharshene Karthik, TharunSelvam Mahendran, M K Jaganathan, Sanjana Prakash Hemdev
{"title":"长链非编码rna在胰腺癌中的作用和贡献。","authors":"K T Ramya Devi,&nbsp;Dharshene Karthik,&nbsp;TharunSelvam Mahendran,&nbsp;M K Jaganathan,&nbsp;Sanjana Prakash Hemdev","doi":"10.1080/21541264.2021.1922071","DOIUrl":null,"url":null,"abstract":"<p><p>Noncoding RNAs are proclaimed to be expressed in various cancer types and one such type is found to be pancreatic ductal adenocarcinoma (PDAC). The long noncoding RNAs (LncRNAs) affect the migration, invasion, and growth of tumor cells by playing important roles in the process of epigenesis, post-transcription, and transcriptional regulation along with the maintenance of apoptosis and cell cycle. It is quite subtle whether the alterations in lncRNAs would impact PDAC progression and development. This review throws a spotlight on the lncRNAs associated with tumor functions: MALAT-1, HOTAIR, HOXA13, H19, LINC01559, LINC00460, SNHG14, SNHG16, DLX6-AS1, MSC-AS1, ABHD11-AS1, DUXAP8, DANCR, XIST, DLEU2, etc. are upregulated lncRNAs whereas GAS5, HMlincRNA717, MIAT, LINC01111, lncRNA KCNK15-AS1, etc. are downregulated lncRNAs inhibiting the invasion and progression of PDAC. These data provided helps in the assessment of lncRNAs in the development, metastasis, and occurrence of PDAC and also play a vital role in the evolution of biomarkers and therapeutic agents for the treatment of PDAC.</p>","PeriodicalId":47009,"journal":{"name":"Transcription-Austin","volume":"12 1","pages":"12-27"},"PeriodicalIF":3.6000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21541264.2021.1922071","citationCount":"8","resultStr":"{\"title\":\"Long noncoding RNAs: role and contribution in pancreatic cancer.\",\"authors\":\"K T Ramya Devi,&nbsp;Dharshene Karthik,&nbsp;TharunSelvam Mahendran,&nbsp;M K Jaganathan,&nbsp;Sanjana Prakash Hemdev\",\"doi\":\"10.1080/21541264.2021.1922071\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Noncoding RNAs are proclaimed to be expressed in various cancer types and one such type is found to be pancreatic ductal adenocarcinoma (PDAC). The long noncoding RNAs (LncRNAs) affect the migration, invasion, and growth of tumor cells by playing important roles in the process of epigenesis, post-transcription, and transcriptional regulation along with the maintenance of apoptosis and cell cycle. It is quite subtle whether the alterations in lncRNAs would impact PDAC progression and development. This review throws a spotlight on the lncRNAs associated with tumor functions: MALAT-1, HOTAIR, HOXA13, H19, LINC01559, LINC00460, SNHG14, SNHG16, DLX6-AS1, MSC-AS1, ABHD11-AS1, DUXAP8, DANCR, XIST, DLEU2, etc. are upregulated lncRNAs whereas GAS5, HMlincRNA717, MIAT, LINC01111, lncRNA KCNK15-AS1, etc. are downregulated lncRNAs inhibiting the invasion and progression of PDAC. These data provided helps in the assessment of lncRNAs in the development, metastasis, and occurrence of PDAC and also play a vital role in the evolution of biomarkers and therapeutic agents for the treatment of PDAC.</p>\",\"PeriodicalId\":47009,\"journal\":{\"name\":\"Transcription-Austin\",\"volume\":\"12 1\",\"pages\":\"12-27\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2021-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/21541264.2021.1922071\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transcription-Austin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/21541264.2021.1922071\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/5/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transcription-Austin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21541264.2021.1922071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 8

摘要

非编码rna被认为在多种癌症类型中表达,其中一种类型是胰腺导管腺癌(PDAC)。长链非编码rna (long noncoding rna, LncRNAs)在肿瘤细胞的表观发生、转录后、转录调控等过程中发挥重要作用,并维持细胞凋亡和细胞周期,影响肿瘤细胞的迁移、侵袭和生长。lncrna的改变是否会影响PDAC的进展和发展尚不清楚。本文综述了与肿瘤功能相关的lncRNA: MALAT-1、HOTAIR、HOXA13、H19、LINC01559、LINC00460、SNHG14、SNHG16、DLX6-AS1、mscs - as1、ABHD11-AS1、DUXAP8、DANCR、XIST、dle2等为上调lncRNA,而GAS5、HMlincRNA717、MIAT、LINC01111、lncRNA KCNK15-AS1等为下调lncRNA,抑制PDAC的侵袭和进展。这些数据有助于评估lncrna在PDAC的发展、转移和发生中的作用,也对PDAC治疗的生物标志物和治疗药物的发展起着至关重要的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Long noncoding RNAs: role and contribution in pancreatic cancer.

Noncoding RNAs are proclaimed to be expressed in various cancer types and one such type is found to be pancreatic ductal adenocarcinoma (PDAC). The long noncoding RNAs (LncRNAs) affect the migration, invasion, and growth of tumor cells by playing important roles in the process of epigenesis, post-transcription, and transcriptional regulation along with the maintenance of apoptosis and cell cycle. It is quite subtle whether the alterations in lncRNAs would impact PDAC progression and development. This review throws a spotlight on the lncRNAs associated with tumor functions: MALAT-1, HOTAIR, HOXA13, H19, LINC01559, LINC00460, SNHG14, SNHG16, DLX6-AS1, MSC-AS1, ABHD11-AS1, DUXAP8, DANCR, XIST, DLEU2, etc. are upregulated lncRNAs whereas GAS5, HMlincRNA717, MIAT, LINC01111, lncRNA KCNK15-AS1, etc. are downregulated lncRNAs inhibiting the invasion and progression of PDAC. These data provided helps in the assessment of lncRNAs in the development, metastasis, and occurrence of PDAC and also play a vital role in the evolution of biomarkers and therapeutic agents for the treatment of PDAC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Transcription-Austin
Transcription-Austin BIOCHEMISTRY & MOLECULAR BIOLOGY-
CiteScore
6.50
自引率
5.60%
发文量
9
期刊最新文献
Harnessing transcription factors for therapeutic purposes. Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering. Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery. Minimization and complete loss of general transcription factor proteins in the intracellular parasite Encephalitozoon cuniculi. Negative feedback systems for modelling NF-κB transcription factor oscillatory activity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1